Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Advanced Non-hematologic Malignancies × ixazomib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Multiple Myeloma 9 Lymphoma 4 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Leukemia, Myeloid, Acute 2 Sarcoma, Ewing 1 Sarcoma, Alveolar Soft Part 1 Sarcoma 1 Recurrence 1 Neurofibrosarcoma 1 Neoplasms, Plasma Cell 1 Neoplasms 1 Liposarcoma 1 Leukemia, Plasma Cell 1 Leukemia, Biphenotypic, Acute 1 Immunoglobulin Light-chain Amyloidosis 1 Hematologic Neoplasms 1 Advanced Non-hematologic Malignancies 1 Advanced Cancers 1

Interventions

ixazomib 1 TAK 733 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00830869 2019-09-09

A Phase 1 Study of IXAZOMIB in Adult Patients With Advanced Nonhematologic Malignancies

Takeda

Phase 1 Completed

116 enrolled 33 charts

Advanced Non-hematologic Malignancies

Data powered by HemOnc (CC BY 4.0) Colophon ⚡